vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and Janus International Group, Inc. (JBI). Click either name above to swap in a different company.
Janus International Group, Inc. is the larger business by last-quarter revenue ($219.3M vs $168.4M, roughly 1.3× Esperion Therapeutics, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs -4.7%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs -8.8%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
Janus Henderson is a British-American global asset management group headquartered in the City of London, United Kingdom. It offers a range of financial products to individuals, intermediary advisors, and institutional investors globally under the trade name Janus Henderson Investors.
ESPR vs JBI — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $219.3M |
| Net Profit | — | $15.2M |
| Gross Margin | — | 39.1% |
| Operating Margin | 50.6% | 13.4% |
| Net Margin | — | 6.9% |
| Revenue YoY | 143.7% | -4.7% |
| Net Profit YoY | — | 28.8% |
| EPS (diluted) | $0.32 | $0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.4M | — | ||
| Q3 25 | $87.3M | $219.3M | ||
| Q2 25 | $82.4M | $228.1M | ||
| Q1 25 | $65.0M | $210.5M | ||
| Q4 24 | $69.1M | $230.8M | ||
| Q3 24 | $51.6M | $230.1M | ||
| Q2 24 | $73.8M | $248.4M | ||
| Q1 24 | $137.7M | $254.5M |
| Q4 25 | — | — | ||
| Q3 25 | $-31.3M | $15.2M | ||
| Q2 25 | $-12.7M | $20.7M | ||
| Q1 25 | $-40.5M | $10.8M | ||
| Q4 24 | — | $300.0K | ||
| Q3 24 | $-29.5M | $11.8M | ||
| Q2 24 | $-61.9M | $27.6M | ||
| Q1 24 | $61.0M | $30.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | 39.1% | ||
| Q2 25 | — | 40.9% | ||
| Q1 25 | — | 38.9% | ||
| Q4 24 | — | 37.8% | ||
| Q3 24 | — | 39.6% | ||
| Q2 24 | — | 43.9% | ||
| Q1 24 | — | 43.4% |
| Q4 25 | 50.6% | — | ||
| Q3 25 | -11.4% | 13.4% | ||
| Q2 25 | 8.6% | 15.8% | ||
| Q1 25 | -34.0% | 12.0% | ||
| Q4 24 | -6.4% | 5.5% | ||
| Q3 24 | -31.0% | 11.6% | ||
| Q2 24 | 3.5% | 20.8% | ||
| Q1 24 | 52.5% | 21.8% |
| Q4 25 | — | — | ||
| Q3 25 | -35.9% | 6.9% | ||
| Q2 25 | -15.4% | 9.1% | ||
| Q1 25 | -62.2% | 5.1% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | -57.2% | 5.1% | ||
| Q2 24 | -83.9% | 11.1% | ||
| Q1 24 | 44.3% | 12.1% |
| Q4 25 | $0.32 | — | ||
| Q3 25 | $-0.16 | $0.11 | ||
| Q2 25 | $-0.06 | $0.15 | ||
| Q1 25 | $-0.21 | $0.08 | ||
| Q4 24 | $-0.14 | $0.01 | ||
| Q3 24 | $-0.15 | $0.08 | ||
| Q2 24 | $-0.33 | $0.19 | ||
| Q1 24 | $0.34 | $0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-302.0M | $560.8M |
| Total Assets | $465.9M | $1.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | — | ||
| Q3 25 | $92.4M | — | ||
| Q2 25 | $86.1M | — | ||
| Q1 25 | $114.6M | — | ||
| Q4 24 | $144.8M | — | ||
| Q3 24 | $144.7M | $102.1M | ||
| Q2 24 | $189.3M | $110.1M | ||
| Q1 24 | $226.6M | — |
| Q4 25 | $-302.0M | — | ||
| Q3 25 | $-451.4M | $560.8M | ||
| Q2 25 | $-433.5M | $543.8M | ||
| Q1 25 | $-426.2M | $526.8M | ||
| Q4 24 | $-388.7M | $518.8M | ||
| Q3 24 | $-370.2M | $526.6M | ||
| Q2 24 | $-344.2M | $556.3M | ||
| Q1 24 | $-294.3M | $535.4M |
| Q4 25 | $465.9M | — | ||
| Q3 25 | $364.0M | $1.3B | ||
| Q2 25 | $347.1M | $1.3B | ||
| Q1 25 | $324.0M | $1.3B | ||
| Q4 24 | $343.8M | $1.3B | ||
| Q3 24 | $314.1M | $1.3B | ||
| Q2 24 | $352.3M | $1.3B | ||
| Q1 24 | $373.1M | $1.4B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $15.0M |
| Free Cash FlowOCF − Capex | — | $8.3M |
| FCF MarginFCF / Revenue | — | 3.8% |
| Capex IntensityCapex / Revenue | 0.0% | 3.1% |
| Cash ConversionOCF / Net Profit | — | 0.99× |
| TTM Free Cash FlowTrailing 4 quarters | — | $140.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.2M | — | ||
| Q3 25 | $-4.3M | $15.0M | ||
| Q2 25 | $-31.4M | $51.4M | ||
| Q1 25 | $-22.6M | $48.3M | ||
| Q4 24 | $-35.0M | $51.4M | ||
| Q3 24 | $-35.3M | $43.0M | ||
| Q2 24 | $-7.2M | $31.0M | ||
| Q1 24 | $53.8M | $28.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | $8.3M | ||
| Q2 25 | — | $44.6M | ||
| Q1 25 | — | $41.9M | ||
| Q4 24 | — | $45.3M | ||
| Q3 24 | $-35.5M | $39.3M | ||
| Q2 24 | $-7.3M | $25.3M | ||
| Q1 24 | $53.8M | $24.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | 3.8% | ||
| Q2 25 | — | 19.6% | ||
| Q1 25 | — | 19.9% | ||
| Q4 24 | — | 19.6% | ||
| Q3 24 | -68.7% | 17.1% | ||
| Q2 24 | -9.9% | 10.2% | ||
| Q1 24 | 39.0% | 9.4% |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | 3.1% | ||
| Q2 25 | 0.0% | 3.0% | ||
| Q1 25 | 0.0% | 3.0% | ||
| Q4 24 | 0.0% | 2.6% | ||
| Q3 24 | 0.3% | 1.6% | ||
| Q2 24 | 0.1% | 2.3% | ||
| Q1 24 | 0.1% | 1.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.99× | ||
| Q2 25 | — | 2.48× | ||
| Q1 25 | — | 4.47× | ||
| Q4 24 | — | 171.33× | ||
| Q3 24 | — | 3.64× | ||
| Q2 24 | — | 1.12× | ||
| Q1 24 | 0.88× | 0.93× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
JBI
| Self Storage New Construction | $72.3M | 33% |
| Commercial And Others | $65.5M | 30% |
| Self Storage R3 | $54.0M | 25% |
| Transferred At Point In Time | $15.5M | 7% |
| Transferred Over Time | $12.8M | 6% |
